Intended for healthcare professionals

Editor's Choice

Disentangling ourselves from “Big Formula”

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k5146 (Published 06 December 2018) Cite this as: BMJ 2018;363:k5146
  1. Fiona Godlee, editor in chief
  1. The BMJ
  1. fgodlee{at}bmj.com
    Follow Fiona on Twitter @fgodlee

Despite decades of effort to curb the promotion of infant formula, sales are flourishing and breastfeeding is in decline, especially in the UK. Earlier this year we heard about the resurgent influence of “Big Formula,” with industry lobbying and funding for medical education harming babies and mothers around the world (doi:10.1136/bmj.k3577). This week we investigate one small but influential corner of the multibillion pound formula industry: the promotion of specialist formula for treating cow’s milk protein allergy (CMPA).

Chris van Tulleken finds a worrying range of deeply embedded relationships …

View Full Text